EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic failure of multidrug therapy for leprosy: A retrospective case series in a hyperendemic Brazilian City

Andrea Maia Fernandes de Araújo Fonseca iD, Patrícia Sammarco Rosa, Andrea de Faria Fernandes Belone, Cleverson Teixeira Soares, Daniele de Faria Ferreira Bertoluci, Suzana Madeira Diório, Luciana Raquel Vincenzi Fachin, Rodrigo Feliciano do Carmo, Francisco Bezerra de Almeida Neto

PLOS Neglected Tropical Diseases · 25.11.2025 · 19 (11) · e0013616

DOI: 10.1371/journal.pntd.0013616 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 25.11.2025. Verfasst von Andrea Maia Fernandes de Araújo Fonseca und 8 weiteren Autor:innen. Beteiligte Einrichtung: Federal University of the São Francisco Valley, Postgraduate program in Health and Biological Sciences, Petrolina, Pernambuco, Brazil. Hauptthemen laut MEDLINE: Mycobacterium leprae, Leprostatic Agents, Leprosy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordination for the Improvement of Higher Education Personnel – Brazil (CAPES), Coordination for the Improvement of Higher Education Personnel – Brazil.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Leprosy remains endemic in many regions despite the global rollout of multidrug therapy (MDT). Clinical cure—defined by completion of a time-based MDT regimen—may not reflect proper bacteriological clearance, particularly in patients with persistent reactions or neurological symptoms. We aimed to assess subclinical disease activity in multibacillary patients who completed an extended 24-dose MDT course.

Methods

In this retrospective case series, between January 2016 and November 2023, 131 multibacillary patients treated at the Petrolina Infectious Diseases Service (SEINPE) underwent skin biopsy upon completing 24 monthly MDT doses. Disease activity was evaluated by histopathology (H&E and Fite–Faraco staining; n = 123), slit-skin smear with bacilloscopic and morphological indices (BI, n = 126; MI, n = 74), qPCR for M. leprae (n = 101), and nude mice footpad inoculation (n = 45) at Instituto Lauro de Souza Lima, Bauru, Brazil. Drug-resistance mutations were detected by sequencing ( folP1, rpoB, gyrA ; n = 88). Neurological function was assessed using a Simplified Neurological Assessment (n = 117).

Results

Histopathology revealed active disease or bacillary persistence in 62/123 specimens (50.41%), while 29/45 inoculations (64.44%) yielded viable bacilli. qPCR detected M. leprae DNA in 96/101 patients (95.05%). Known resistance mutations were identified in 2/88 patients (2.27%). Clinically, 89/131 patients (67.94%) no longer exhibited skin lesions post-MDT; however, neurological impairment increased from 70/131 (53.44%) at diagnosis to 114/131 (87.02%) at discharge. The proportion with grade 2 disability increased from 5/100 (5.00%) to 27/117 (23.08%). Exact 95% CIs are reported in the manuscript.

Conclusions

More than half of patients treated with an extended 24-dose MDT regimen harbored persistent M. leprae activity despite apparent dermatological cure, and most experienced worsening neural function. Time-based discharge criteria alone are inadequate to confirm cure. We recommend integrating post-treatment histopathological, molecular, and inoculation assessments—particularly in patients with persistent reactions or neurological complaints—to identify therapeutic failure, guide retreatment, and prevent long-term disability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium lepraeLeprostatic AgentsLeprosyRetrospective StudiesHumansFemaleMaleAdultMiddle AgedBrazilAnimalsDrug Therapy, CombinationTreatment FailureMiceYoung AdultAgedAdolescentDrug Resistance, Multiple, BacterialMice, NudeSkin

Substanzen

Leprostatic Agents

Autor:innen und Institutionen

  • Federal University of the São Francisco Valley, Postgraduate program in Health and Biological Sciences, Petrolina, Pernambuco, Brazil.
  • Division of Research and Education, Lauro de Souza Lima Institute, Bauru, São Paulo, Brazil.
  • Department of Dermatology, Medicine, Maurício de Nassau University Center, Recife, Pernambuco, Brazil.

ORCID-Profile: Andrea Maia Fernandes de Araújo Fonseca

Förderung

  • Coordination for the Improvement of Higher Education Personnel – Brazil (CAPES)
  • Coordination for the Improvement of Higher Education Personnel – Brazil

Zitieren

APA

Fonseca, A. M. F. A., Rosa, P. S., Belone, A. F. F., Soares, C. T., Bertoluci, D. F. F., Diório, S. M., Fachin, L. R. V., do Carmo, R. F., & de Almeida Neto, F. B. (2025). Therapeutic failure of multidrug therapy for leprosy: A retrospective case series in a hyperendemic Brazilian City. PLOS Neglected Tropical Diseases, 19(11), e0013616. https://doi.org/10.1371/journal.pntd.0013616

Vancouver

Fonseca AMFA, Rosa PS, Belone AFF, Soares CT, Bertoluci DFF, Diório SM, et al. Therapeutic failure of multidrug therapy for leprosy: A retrospective case series in a hyperendemic Brazilian City. PLOS Neglected Tropical Diseases. 2025;19(11):e0013616. doi:10.1371/journal.pntd.0013616

BibTeX
@article{Fonseca2025,
  author = {Fonseca, Andrea Maia Fernandes de Araújo and Rosa, Patrícia Sammarco and Belone, Andrea de Faria Fernandes and Soares, Cleverson Teixeira and Bertoluci, Daniele de Faria Ferreira and Diório, Suzana Madeira and Fachin, Luciana Raquel Vincenzi and do Carmo, Rodrigo Feliciano and de Almeida Neto, Francisco Bezerra},
  title = {Therapeutic failure of multidrug therapy for leprosy: A retrospective case series in a hyperendemic Brazilian City},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  volume = {19},
  number = {11},
  pages = {e0013616},
  doi = {10.1371/journal.pntd.0013616}
}
Kostenlos starten →